Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Nicorandil on Rheumatoid Arthritis Patients
Sponsor: Ain Shams University
Summary
The aim of this clinical trial is to determine whether nicorandil works in minimizing disease severity in patients with rheumatoid arthritis. The study will also assess the safety and tolerability of nicorandil. The main questions it aims to answer are: * Could nicorandil improve disease severity and symptoms of rheumatoid arthritis? * Does nicorandil lower the number of times participants need to use pain relieve medications? * Does the nicorandil improve participants functionality and ability to carry out daily activity? * Does nicorandil correct disease-associated damage and inflammation? * What side effects do participants have when taking nicorandil? Researchers will compare nicorandil to a placebo (a look-alike substance that contains no drug) to see if nicorandil works to decrease symptoms and severity of rheumatoid arthritis. Participants will: * Take nicorandil or a placebo two times daily for 3 months * Visit the clinic once every month for checkups * Keep a diary of their symptoms and the number of times they use a pain reliever
Official title: The Effect of Nicorandil on Disease Activity in Rheumatoid Arthritis Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-09-06
Completion Date
2027-07
Last Updated
2026-09-16
Healthy Volunteers
No
Conditions
Interventions
Nicorandil Oral Tablet
Nicorandil 10 mg oral tablets will be taken as one tablet twice daily for 3 months (12 weeks).
Placebo
Placebo oral tablets will be taken as one tablet twice daily for 3 months (12 weeks).
conventional synthetic antirheumatic drugs (cDMARDs)
A single or combination of cDMARDs and dose depend on disease severity.
Locations (1)
Ain Shams University Hospitals
Cairo, Abbasia, Egypt